Analystreport

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $53.00 price target on the stock.

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com